Calcium-Independent PLA2Beta in Beta-Cell Apoptosis
Calcium-Independent PLA2Beta in Beta-Cell Apoptosis
批准号:
7258377
负责人:
SASANKA RAMANADHAM
金额:
$28.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-09-30 至 2009-07-31
关键词:
ApoptosisApoptoticArachidonic AcidsAttenuatedBeta CellBiochemicalCalciumCaspaseCell SurvivalCell membraneCell physiologyCellsCeramidesChimeric ProteinsCleaved cellComplexConditionConsensus SequenceCytosolCytosolic Phospholipase A2DNADiabetes MellitusEndoplasmic ReticulumFunctional disorderGenerationsGolgi ApparatusHTATIP geneHydrolysisImmunoblottingIn Situ Nick-End LabelingInsulin-Dependent Diabetes MellitusIslet CellIslets of LangerhansLinkLipaseMAP Kinase GeneMass Spectrum AnalysisMediatingMediator of activation proteinMembraneMonitorMusMutateMutationNatureNon-Insulin-Dependent Diabetes MellitusNuclearNumbersOrganellesPLA2G4A genePathway interactionsPhospholipase A2PhospholipidsPhosphorylationPolymerase Chain ReactionProcessProtein IsoformsProteinsProtocols documentationRestRoleSignal TransductionSiteSpectrometrySpectrometry, Mass, Electrospray IonizationStimulusStressTestingTimecaspase-3human PLA2G4A proteinin vivoinsulinomaisletlipid mediatorpreventtype I and type II diabetes
中文摘要
描述(由申请人提供):内质网(ER)应激导致β细胞凋亡,而内质网应激通过钙非依赖性磷脂酶A2(iPLA2β)抑制内质网(ER)诱导的β细胞凋亡,我们的假设是iPLA2β参与内质网应激诱导的β细胞凋亡。在1型和2型糖尿病(DM)中,β细胞的凋亡都会导致β细胞的丧失和β细胞功能的降低。因此,如果要阻止或推迟这一过程,了解β细胞凋亡的潜在机制是很重要的。β细胞的分泌特性赋予它们高度发达的内质网,使它们容易受到内质网压力的影响。这一过程被认为促进了β细胞的凋亡,并在一定程度上导致了T2 DM患者β细胞质量和β细胞功能障碍的减少。IPLA2β催化膜磷脂中花生四烯酸的水解,在β细胞中具有信号转导作用。我们观察到,内质网应激诱导的β细胞凋亡与iPLA2β的表达水平有关,与caspase-3裂解的iPLA2β亚型在核周聚集以及花生四烯酸和神经酰胺的生成增加有关,并被iPLA2β抑制。IPLA2β失活也可减弱内质网应激诱导的胰岛细胞凋亡,iPLA2β-KO胰岛对内质网应激较不敏感。我们建议通过以下目的进一步研究iPLA2a在胰岛(野生型和iPLA2β-KO)和INS-1细胞(亲本,iPLA2β过表达和iPLA2β-KO)中的作用:目的1利用诱导a细胞凋亡和内质网应激的刺激,表征iPLA2β在β细胞凋亡中的参与。目的2通过在a细胞中表达截短和突变的iPLA2β亚型,研究iPLA2β亚型在β细胞凋亡中的作用和亚细胞定位。目的3是利用ESI/MS/MS方法鉴定内质网应激过程中iPLA2β的β细胞亚细胞磷脂底物。目的4通过LC/ESI/MS/MS和生化分析,研究iPLA2β磷酸化及其衍生的花生四烯酸在β细胞凋亡中的作用。
英文摘要
DESCRIPTION (provided by applicant): Endoplasmic reticulum (ER) stress leads to beta-cell apoptosis that is suppressed by inhibition of the Group VIA Ca2+-independent phospholipase A2 (iPLA2beta), and our hypothesis is that iPLA2beta participates in ER stress-induced beta-cell apoptosis. In both type 1 and type 2 diabetes mellitus (DM), beta-cell apoptosis contributes to the loss of beta-cells and decreases in beta-cell function. It is therefore important to understand the mechanisms underlying beta-cell apoptosis if this process is to be prevented or delayed. The secretory nature of beta-cells endows them with a highly developed ER making them susceptible to ER stress. This process is suggested to promote beta-cell apoptosis and, in part, contribute to the decreases in beta-cell mass and beta-cell dysfunction in T2DM. The iPLA2beta catalyzes hydrolysis of arachidonic acid from membrane phospholipids and has a signal transduction role in beta-cells. We observed that ER stress-induced beta-cell apoptosis is related to the levels of iPLA2beta expression, is associated with perinuclear accumulation of a caspase-3-cleaved iPLA2beta isoform and increased generation of arachidonic acid and ceramides, and is suppressed by iPLA2beta inhibition. ER stress-induced apoptosis of pancreatic islets is also attenuated by inactivation of iPLA2beta and iPLA2beta -KO islets are less susceptible to ER stress. We propose to further examine the role of iPLA2a in a-cell apoptosis using pancreatic islets (wild type and iPLA2beta -KO) and INS-1 cells (parental, iPLA2beta over expressing, and iPLA2beta -KO) through the following Aims: Aim 1 is to characterize participation of iPLA2beta in beta-cell apoptosis using stimuli that induce both a-cell apoptosis and ER stress. Aim 2 is to examine the roles and subcellular localization of iPLA2beta isoforms in beta-cell apoptosis by expressing truncated and mutated iPLA2beta isoforms in a-cells. Aim 3 is to identify beta-cell subcellular phospholipid substrates for iPLA2beta during ER stress using ESI/MS/MS protocols. Aim 4 is to examine involvement of iPLA2beta phosphorylation and iPLA2beta -derived arachidonic acid in beta-cell apoptosis using LC/ESI/MS/MS and biochemical analyses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Exploiting iPLA2β-modified macrophages as immunotherapy for T1D
-
批准号:10431074
-
项目类别:
-
资助金额:$21.71万
-
财政年份:2022
-
负责人:SASANKA RAMANADHAM
-
依托单位:
Exploiting iPLA2β-modified macrophages as immunotherapy for T1D
-
批准号:10620299
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2022
-
负责人:SASANKA RAMANADHAM
-
依托单位:
Importance of immune-cell lipid signaling in events leading to type 1 diabetes
-
批准号:9807734
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2019
-
负责人:SASANKA RAMANADHAM
-
依托单位:
Contribution of β-Cell- & Immune Cell-Derived Lipids to β-Cell Death and Diabetes
-
批准号:9315157
-
项目类别:
-
资助金额:$38.97万
-
财政年份:2016
-
负责人:SASANKA RAMANADHAM
-
依托单位:
Contribution of β-Cell- & Immune Cell-Derived Lipids to β-Cell Death and Diabetes
-
批准号:9159460
-
项目类别:
-
资助金额:$38.97万
-
财政年份:2016
-
负责人:SASANKA RAMANADHAM
-
依托单位:
HIV-PROTEASE INHIBITORS SUPPRESS SKELETAL MUSCLE FATTY ACID OXIDATION
-
批准号:8361453
-
项目类别:
-
资助金额:$1.47万
-
财政年份:2011
-
负责人:SASANKA RAMANADHAM
-
依托单位:
AGE-RELATED CHANGES IN BONE MORPHOLOGY ARE ACCELERATED IN GROUP VIA
-
批准号:8168762
-
项目类别:
-
资助金额:$1.13万
-
财政年份:2010
-
负责人:SASANKA RAMANADHAM
-
依托单位:
AGE-RELATED CHANGES IN BONE MORPHOLOGY ARE ACCELERATED IN GROUP VIA
-
批准号:7954015
-
项目类别:
-
资助金额:$0.56万
-
财政年份:2009
-
负责人:SASANKA RAMANADHAM
-
依托单位:
ISLET COMPLEX LIPID IN GROUP VIA CALCIUM INDEPENDENT PHOSPHOLIPASE A2 IN B CELL
-
批准号:7355207
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2006
-
负责人:SASANKA RAMANADHAM
-
依托单位:
GROUP VIA PHOSPHOLIPASE A2 IN ENDOPLASMIC RETICULUM STRESS INDUCED APOPTOSIS
-
批准号:7355180
-
项目类别:
-
资助金额:$0.59万
-
财政年份:2006
-
负责人:SASANKA RAMANADHAM
-
依托单位:
GROUP VIA PHOSPHOLIPASE A2 IN ENDOPLASMIC RETICULUM STRESS INDUCED APOPTOSIS
-
批准号:7180117
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2005
-
负责人:SASANKA RAMANADHAM
-
依托单位:
FATTY ACYL COA DESATURASE ENZYMES ARE EXPRESSED IN INSULIN SECRETING BETA CELLS
-
批准号:7180119
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2005
-
负责人:SASANKA RAMANADHAM
-
依托单位:
ISLET COMPLEX LIPID IN GROUP VIA CALCIUM INDEPENDENT PHOSPHOLIPASE A2 IN B CELL
-
批准号:7180165
-
项目类别:
-
资助金额:$0.54万
-
财政年份:2005
-
负责人:SASANKA RAMANADHAM
-
依托单位:
IPLA2? EXPRESSION & INSULIN SECRETION IN 832 & 12 INS 1 CELLS
-
批准号:7180118
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2005
-
负责人:SASANKA RAMANADHAM
-
依托单位:
CALCIUM-INDEPENDENT PLA2BETA IN BETA-CELL APOPTOSIS
-
批准号:8451569
-
项目类别:
-
资助金额:$26.35万
-
财政年份:2004
-
负责人:SASANKA RAMANADHAM
-
依托单位:
Calcium-Independent PLA2Beta in Beta-Cell Apoptosis
-
批准号:7098852
-
项目类别:
-
资助金额:$29.58万
-
财政年份:2004
-
负责人:SASANKA RAMANADHAM
-
依托单位:
CALCIUM-INDEPENDENT PLA2BETA IN BETA-CELL APOPTOSIS
-
批准号:7783955
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2004
-
负责人:SASANKA RAMANADHAM
-
依托单位:
Calcium-Independent PLA2Beta in Beta-Cell Apoptosis
-
批准号:6951856
-
项目类别:
-
资助金额:$30.29万
-
财政年份:2004
-
负责人:SASANKA RAMANADHAM
-
依托单位:
Calcium-Independent PLA2Beta in Beta-Cell Apoptosis
-
批准号:6854097
-
项目类别:
-
资助金额:$30.29万
-
财政年份:2004
-
负责人:SASANKA RAMANADHAM
-
依托单位:
CALCIUM-INDEPENDENT PLA2BETA IN BETA-CELL APOPTOSIS
-
批准号:8248593
-
项目类别:
-
资助金额:$28.93万
-
财政年份:2004
-
负责人:SASANKA RAMANADHAM
-
依托单位:
海外基金